UH
GILD icon

Unigestion Holding’s Gilead Sciences GILD Stock Holding History

Unigestion Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.32M Buy
+38,596
New +$3.98M 0.25% 86
2024
Q3 		– Sell
-146,038
Closed -$11.8M – 170
2024
Q2 		$11.8M Buy
146,038
+589
+0.4% +$39.3K 0.65% 51
2024
Q1 		$10.7M Sell
145,449
-589
-0.4% -$45.3K 0.52% 64
2023
Q4 		$11.8M Sell
146,038
-72,191
-33% -$5.62M 0.65% 51
2023
Q3 		$16.4M Sell
218,229
-14,341
-6% -$1.1M 1% 34
2023
Q2 		$17.7M Sell
232,570
-96,912
-29% -$7.73M 1.02% 35
2023
Q1 		$26.8M Buy
329,482
+22,054
+7% +$1.83M 1.46% 23
2022
Q4 		$26.2M Sell
307,428
-26,615
-8% -$2.11M 1.39% 22
2022
Q3 		$21.1M Buy
334,043
+207,411
+164% +$13.1M 1.22% 27
2022
Q2 		$7.83M Buy
126,632
+39,845
+46% +$2.47M 0.44% 56
2022
Q1 		$5.16M Buy
+86,787
New +$5.55M 0.22% 64
2021
Q3 		– Sell
-25,521
Closed -$1.73M – 211
2021
Q2 		$1.73M Sell
25,521
-1,090,750
-98% -$72.8M 0.06% 107
2021
Q1 		$72.1M Sell
1,116,271
-459,377
-29% -$29.6M 2.56% 10
2020
Q4 		$91.8M Buy
1,575,648
+230,919
+17% +$13.9M 3.14% 9
2020
Q3 		$84.9M Buy
1,344,729
+1,285,450
+2,168% +$89.1M 2.92% 9
2020
Q2 		$4.56M Sell
59,279
-21,748
-27% -$1.67M 0.15% 75
2020
Q1 		$6.06M Buy
+81,027
New +$5.6M 0.23% 73
2019
Q3 		$6.7M Sell
105,678
-12,851
-11% -$840K 0.19% 95
2019
Q2 		$8.01M Sell
118,529
-18,422
-13% -$1.21M 0.21% 89
2019
Q1 		$8.9M Sell
136,951
-172,618
-56% -$11.5M 0.24% 90
2018
Q4 		$19.4M Sell
309,569
-76,003
-20% -$5.31M 0.49% 70
2018
Q3 		$29.8M Sell
385,572
-211,953
-35% -$16M 0.63% 58
2018
Q2 		$42.3M Buy
+597,525
New +$42.2M 0.84% 40

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Unigestion Holding's GILD Position: Q1 2025 in Review

Unigestion Holding opened a new position in Gilead Sciences (GILD) in Q1 2025: 38,596 shares worth $4.32M. The stake represents 0.25% of the portfolio and ranks #86 among its holdings. This is a return to the name: Unigestion Holding previously reported a position in GILD as recently as Q2 2024.

Unigestion Holding first reported a position in GILD in Q2 2018 and has held it in 23 quarters since. The position peaked at $91.8M in Q4 2020. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Unigestion Holding held 38,596 shares of Gilead Sciences worth $4.32M as of Q1 2025.
  • Gilead Sciences was a new Unigestion Holding position in Q1 2025.
  • Gilead Sciences made up 0.25% of Unigestion Holding's portfolio in Q1 2025, its #86 holding.
  • Unigestion Holding first reported a position in Gilead Sciences in Q2 2018 and has held it in 23 quarters since.
  • Unigestion Holding's Gilead Sciences position peaked at $91.8M in Q4 2020.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.